On the Frontlines of Psoriasis

Recognizing the Mental Burden of Psoriasis

Guest: Mio Nakamura, MD, MS Host: Steve Jackson, PharmD Psoriasis is more than a visible skin condition; it carries a profound psychological and emotional burden that can disrupt patients’ quality of life. In this conversation with Dr. Steve Jackson, Dr. Mio Nakamura shares practical insights on recognizing mental health impacts, assessing patient wellbeing beyond clinical severity, and integrating supportive resources into care. Dr. Nakamura is a Clinical Assistant Professor of Dermatology and Director of Clinical Research at the University of Michigan Medical School.

A Personalized Approach to Complex Psoriasis Cases

Host: Ryan Quigley Guest: Jenny Murase, MD Evolving insights into Th1-, Th2-, and Th17-driven inflammation are reshaping the diagnosis and management of patients presenting with mixed psoriasis subtypes. Ryan Quigley sits down with Dr. Jenny Murase to learn more about practical approaches to personalized treatment planning, common clinical pitfalls, and emerging strategies. Dr. Murase is the Founder and Chair of the American Academy of Dermatology Women's Health Expert Resource Group, as well as a Associate Clinical Professor at the UCSF Department of Dermatology and Deputy Chair of the Clinical Guidelines Committee for the American Academy of Dermatology.

Practical Strategies for Improving Adherence in Psoriasis Care

Host: Ryan Quigley Guest: Steven R. Feldman, MD, PhD In psoriasis management, patient adherence is a persistent challenge, especially with topical therapies for mild involvement. Ryan Quigley sits down with Dr. Steve Feldman to explore evidence-based, real-world strategies to support these patients and promote long-term success. Dr. Feldman is a professor of dermatology, pathology, and public health sciences at Wake Forest University School of Medicine as well as a practicing dermatologist at Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina.

Unlocking the Potential of TYK2 Inhibitors in Plaque Psoriasis

Guest: Christopher Bunick, MD, PhD, FAAD Host: Ryan Quigley With high selectivity, durable response, and once-daily dosing, next-generation TYK2 inhibitors offer a promising oral option for patients with moderate-to-severe plaque psoriasis. Ryan Quigley sits down with Dr. Christopher Bunick, Associate Professor of Dermatology and Translational Biomedicine at Yale University School of Medicine, to learn more about how these agents may align with evolving patient preferences and expand options beyond injectables.

Shifting the Script: How Inner Dialogue Influences Psoriasis Progress

Host: Ryan Quigley Guest: Michael Greenberg, MD A patient’s inner dialogue—especially negative self-talk—can influence their perception of disease, adherence to treatment, and emotional wellbeing. Ryan Quigley sits down with Dr. Michael Greenberg, a dermatologist at the Illinois Dermatology Institute, as he shares observations from his own practice, highlighting how recognizing subtle emotional cues and practicing empathetic communication can help support more holistic and sustainable outcomes in psoriasis.